Skip to main content

Table 1 Patient characteristics (N = 11)

From: Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma

Characteristics  
Age, years, median (range) 76 (57–86)
Tumor size, mm, median (range) 53 (27–119)
Sex, number
 Male:Female 9:2
Etiology
 Hepatitis C virus antibody positive 4
 Hepatitis B surface antigen positive 3
 NASH/NAFLD 2
 Unidentified 2
Prior treatment of C-ion RT
 TACE 6
 TACE and RFA 2
 TACE and hepatic artery infusion chemotherapy 2
 Treatment naïve 1
Site of direct invasion
 Major branch of the portal vein 3
 Major branch of the hepatic vein 5
 Both major branches of the portal vein and the hepatic vein 3
Child-Pugh class
 A:B 10:1
Barcelona Clinic Liver Classification Stage
 A:B:C 2:0:9
Albumin-Bilirubin Grade
1:2a:2b:3 3:2:5:1
Pretreatment AFP, IU/ml
  < 200 6
 200–400 2
  > 400 3
Indocyanine green retention rate at 15 min
  < 15% 5
 15–30% 4
  > 30% 2
 Median (range) 15.9 (4.9–108.7)
  1. Abbreviations: AFP alpha-fetoprotein, C-ion RT carbon ion radiotherapy, NASH/NAFLD non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, RFA percutaneous radiofrequency ablation, TACE transarterial chemoembolization